ABSTRACT

KEYWORDS

REFERENCES

1. American Thoracic Society. Dyspnea. Mechanisms, assessment and management: a consensus statement. Am J Respir Crit Care Med 1999;159(1):321-340.

2. Neuman A, Gunnbjörnsdottir M, Tunsäter A, et al. Dyspnea in relation to symptoms of anxiety and depression: A prospective population study. Respir Med 2006;100(10):1843-1849.

3. Bass C, Gardner WN. Respiratory and psychiatric abnormalities in chronic symptomatic hyperventilation. Br Med J (Clin Res Ed) 1985;290(6479):1387-1390.

4. Heim E, Blaser A, Waidelich E. Dyspnea: psychophysiologic relationships. Psychosom Med 1972;34(5):405-423.

5. Han JN, Zhu YJ, Li SW, et al. Medically unexplained dyspnea: psychophysiological characteristics and role of breathing therapy. Chin Med J (Engl) 2004;117(1): 6-13.

6. Kellner R. Psychosomatic syndromes, somatization and somatoform disorders. Psychother Psychosom 1994;61(1-2):4-24.

7. Bach M, Bach D. Alexithymia in somatoform disorder and somatic disease: a comparative study. Psychother Psychosom 1996;65(3):150-152.

8. Lumley MA. Alexithymia and negative emotional conditions. J Psychosom Res 2000;49(1):51-54.

9. Jackson JL, Kroenke K. Prevalence, impact, and prognosis of multisomatoform disorder in primary care: a 5-year follow-up study. Psychosom Med 2008;70(4):430-434.

10. Kroenke K, Rosmalen JG. Symptoms, syndromes, and the value of psychiatric diagnostics in patients who have functional somatic disorders. Med Clin North Am 2006;90(4):603-626.

11. Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005;62(8):903-910.